Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen - PubMed (original) (raw)
. 2001 Apr 15;97(8):2323-32.
doi: 10.1182/blood.v97.8.2323.
Affiliations
- PMID: 11290594
- DOI: 10.1182/blood.v97.8.2323
Free article
Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen
M Seandel et al. Blood. 2001.
Free article
Abstract
The contribution of specific type I collagen remodeling in angiogenesis was studied in vivo using a quantitative chick embryo assay that measures new blood vessel growth into well-defined fibrillar collagen implants. In response to a combination of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), a strong angiogenic response was observed, coincident with invasion into the collagen implants of activated fibroblasts, monocytes, heterophils, and endothelial cells. The angiogenic effect was highly dependent on matrix metalloproteinase (MMP) activity, because new vessel growth was inhibited by both a synthetic MMP inhibitor, BB3103, and a natural MMP inhibitor, TIMP-1. Multiple MMPs were detected in the angiogenic tissue including MMP-2, MMP-13, MMP-16, and a recently cloned MMP-9-like gelatinase. Using this assay system, wild-type collagen was compared to a unique collagenase-resistant collagen (r/r), with regard to the ability of the respective collagen implants to support cell invasion and angiogenesis. It was found that collagenase-resistant collagen constitutes a defective substratum for angiogenesis. In implants made with r/r collagen there was a substantial reduction in the number of endothelial cells and newly formed vessels. The presence of the r/r collagen, however, did not reduce the entry into the implants of other cell types, that is, activated fibroblasts and leukocytes. These results indicate that fibrillar collagen cleavage at collagenase-specific sites is a rate-limiting event in growth factor-stimulated angiogenesis in vivo.
Similar articles
- Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW. Collen A, et al. Blood. 2003 Mar 1;101(5):1810-7. doi: 10.1182/blood-2002-05-1593. Epub 2002 Sep 19. Blood. 2003. PMID: 12393408 - Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B. Anand-Apte B, et al. Invest Ophthalmol Vis Sci. 1997 Apr;38(5):817-23. Invest Ophthalmol Vis Sci. 1997. PMID: 9112976 - Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3).
Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M, Deryugina EI, Quigley JP. Zijlstra A, et al. J Biol Chem. 2004 Jun 25;279(26):27633-45. doi: 10.1074/jbc.M313617200. Epub 2004 Apr 5. J Biol Chem. 2004. PMID: 15066996 - Regulation of Obesity by Antiangiogenic Herbal Medicines.
Shin SS, Yoon M. Shin SS, et al. Molecules. 2020 Oct 4;25(19):4549. doi: 10.3390/molecules25194549. Molecules. 2020. PMID: 33020443 Free PMC article. Review. - Models for studying angiogenesis in vivo.
Ribatti D, Vacca A. Ribatti D, et al. Int J Biol Markers. 1999 Oct-Dec;14(4):207-13. doi: 10.1177/172460089901400403. Int J Biol Markers. 1999. PMID: 10669948 Review.
Cited by
- Enhancing uterine receptivity for embryo implantation through controlled collagenase intervention.
Zehorai E, Gross Lev T, Shimshoni E, Hadas R, Adir I, Golani O, Molodij G, Eitan R, Kadler KE, Kollet O, Neeman M, Dekel N, Solomonov I, Sagi I. Zehorai E, et al. Life Sci Alliance. 2024 Aug 16;7(10):e202402656. doi: 10.26508/lsa.202402656. Print 2024 Oct. Life Sci Alliance. 2024. PMID: 39151945 Free PMC article. - Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma.
Jumaniyazova E, Lokhonina A, Dzhalilova D, Kosyreva A, Fatkhudinov T. Jumaniyazova E, et al. J Pers Med. 2023 Nov 17;13(11):1616. doi: 10.3390/jpm13111616. J Pers Med. 2023. PMID: 38003931 Free PMC article. Review. - Inhibition of Monoacylglycerol Lipase Decreases Angiogenic Features of Endothelial Cells via Release of Tissue Inhibitor of Metalloproteinase-1 from Lung Cancer Cells.
Wittig F, Henkel L, Prüser JL, Merkord J, Ramer R, Hinz B. Wittig F, et al. Cells. 2023 Jun 30;12(13):1757. doi: 10.3390/cells12131757. Cells. 2023. PMID: 37443791 Free PMC article. - Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis.
Wang ZJ, Guan QW, Zhou HH, Mao XY, Chen FH. Wang ZJ, et al. Genes Dis. 2022 May 26;10(3):771-785. doi: 10.1016/j.gendis.2022.05.011. eCollection 2023 May. Genes Dis. 2022. PMID: 37396555 Free PMC article. Review. - Endothelial cell polarity and extracellular matrix composition require functional ATP6AP2 during developmental and pathological angiogenesis.
Patel NR, K C R, Blanks A, Li Y, Prieto MC, Meadows SM. Patel NR, et al. JCI Insight. 2022 Oct 10;7(19):e154379. doi: 10.1172/jci.insight.154379. JCI Insight. 2022. PMID: 35998033 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous